Metabolism and Disposition of Acetaminophen: Recent Advances in Relation to Hepatotoxicity and Diagnosis

Overview

Journal Pharm Res

Specialties Pharmacology
Pharmacy

Date 2013 Mar 7

PMID 23462933

Citations 246

Authors

Mitchell R McGill

Hartmut Jaeschke

Affiliations

Soon will be listed here.

Abstract

Acetaminophen (APAP) is one of the most widely used drugs. Though safe at therapeutic doses, overdose causes mitochondrial dysfunction and centrilobular necrosis in the liver. The first studies of APAP metabolism and activation were published more than 40 years ago. Most of the drug is eliminated by glucuronidation and sulfation. These reactions are catalyzed by UDP-glucuronosyltransferases (UGT1A1 and 1A6) and sulfotransferases (SULT1A1, 1A3/4, and 1E1), respectively. However, some is converted by CYP2E1 and other cytochrome P450 enzymes to a reactive intermediate that can bind to sulfhydryl groups. The metabolite can deplete liver glutathione (GSH) and modify cellular proteins. GSH binding occurs spontaneously, but may also involve GSH-S-transferases. Protein binding leads to oxidative stress and mitochondrial damage. The glucuronide, sulfate, and GSH conjugates are excreted by transporters in the canalicular (Mrp2 and Bcrp) and basolateral (Mrp3 and Mrp4) hepatocyte membranes. Conditions that interfere with metabolism and metabolic activation can alter the hepatotoxicity of the drug. Recent data providing novel insights into these processes, particularly in humans, are reviewed in the context of earlier work, and the effects of altered metabolism and reactive metabolite formation are discussed. Recent advances in the diagnostic use of serum adducts are covered.

Citing Articles

Drug-Induced Liver Injury-Pharmacological Spectrum Among Children.

Maris B, Grama A, Pop T Int J Mol Sci. 2025; 26(5).

PMID: 40076629 PMC: 11901067. DOI: 10.3390/ijms26052006.

Acute Acetaminophen Hepatotoxicity And Platelet Dysfunction.

Ekaney M, Pritt T, Attal N, Murphy C, McKillop I J Med Toxicol. 2025; .

PMID: 40014260 DOI: 10.1007/s13181-025-01065-w.

Two chromatographic methods for analyzing paracetamol in spiked human plasma with its toxic metabolite, N-acetyl parabenzoquinone imine and its antidote, N-acetyl-L-cysteine.

El-Abassy O, Fawzy M, Kamel E Sci Rep. 2025; 15(1):4119.

PMID: 39900950 PMC: 11791058. DOI: 10.1038/s41598-025-86070-3.

Modulation of Paracetamol-Induced Hepatotoxicity by Acute and Chronic Ethanol Consumption in Mice: A Study Pilot.

Goncalves A, Coelho A, da Cruz Castro M, Pereira R, da Silva Araujo N, Ferreira F Toxics. 2025; 12(12.

PMID: 39771072 PMC: 11679532. DOI: 10.3390/toxics12120857.

The Utilization of Acetaminophen for Managing PGE1-Induced Fever in Neonates with Critical Congenital Heart Disease.

Kaya B, Akduman H, Dilli D, Kaya O, Citli R, Zenciroglu A Children (Basel). 2025; 11(12.

PMID: 39767976 PMC: 11727204. DOI: 10.3390/children11121547.

References

Thummel K, Slattery J, Nelson S, Lee C, Pearson P . Effect of ethanol on hepatotoxicity of acetaminophen in mice and on reactive metabolite formation by mouse and human liver microsomes. Toxicol Appl Pharmacol. 1989; 100(3):391-7. DOI: 10.1016/0041-008x(89)90287-1. View

Schiodt F, Ott P, Christensen E, Bondesen S . The value of plasma acetaminophen half-life in antidote-treated acetaminophen overdosage. Clin Pharmacol Ther. 2002; 71(4):221-5. DOI: 10.1067/mcp.2002.121857. View

Yan H, Ramachandran A, Bajt M, Lemasters J, Jaeschke H . The oxygen tension modulates acetaminophen-induced mitochondrial oxidant stress and cell injury in cultured hepatocytes. Toxicol Sci. 2010; 117(2):515-23. PMC: 2940407. DOI: 10.1093/toxsci/kfq208. View

Manautou J, de Waart D, Kunne C, Zelcer N, Goedken M, Borst P . Altered disposition of acetaminophen in mice with a disruption of the Mrp3 gene. Hepatology. 2005; 42(5):1091-8. DOI: 10.1002/hep.20898. View

McGill M, Williams C, Xie Y, Ramachandran A, Jaeschke H . Acetaminophen-induced liver injury in rats and mice: comparison of protein adducts, mitochondrial dysfunction, and oxidative stress in the mechanism of toxicity. Toxicol Appl Pharmacol. 2012; 264(3):387-94. PMC: 3478469. DOI: 10.1016/j.taap.2012.08.015. View

Ghanem C, Gomez P, Arana M, Perassolo M, Ruiz M, Villanueva S . Effect of acetaminophen on expression and activity of rat liver multidrug resistance-associated protein 2 and P-glycoprotein. Biochem Pharmacol. 2004; 68(4):791-8. DOI: 10.1016/j.bcp.2004.05.014. View

Heard K, Green J, James L, Judge B, Zolot L, Rhyee S . Acetaminophen-cysteine adducts during therapeutic dosing and following overdose. BMC Gastroenterol. 2011; 11:20. PMC: 3066114. DOI: 10.1186/1471-230X-11-20. View

Hadi M, Dragovic S, Van Swelm R, Herpers B, van de Water B, Russel F . AMAP, the alleged non-toxic isomer of acetaminophen, is toxic in rat and human liver. Arch Toxicol. 2012; 87(1):155-65. DOI: 10.1007/s00204-012-0924-1. View

Wu Y, Zhang X, Bardag-Gorce F, Robel R, Aguilo J, Chen L . Retinoid X receptor alpha regulates glutathione homeostasis and xenobiotic detoxification processes in mouse liver. Mol Pharmacol. 2004; 65(3):550-7. DOI: 10.1124/mol.65.3.550. View

10.

Win S, Than T, Han D, Petrovic L, Kaplowitz N . c-Jun N-terminal kinase (JNK)-dependent acute liver injury from acetaminophen or tumor necrosis factor (TNF) requires mitochondrial Sab protein expression in mice. J Biol Chem. 2011; 286(40):35071-8. PMC: 3186406. DOI: 10.1074/jbc.M111.276089. View

11.

Hanawa N, Shinohara M, Saberi B, Gaarde W, Han D, Kaplowitz N . Role of JNK translocation to mitochondria leading to inhibition of mitochondria bioenergetics in acetaminophen-induced liver injury. J Biol Chem. 2008; 283(20):13565-77. PMC: 2376214. DOI: 10.1074/jbc.M708916200. View

12.

Cheng J, Ma X, Krausz K, Idle J, Gonzalez F . Rifampicin-activated human pregnane X receptor and CYP3A4 induction enhance acetaminophen-induced toxicity. Drug Metab Dispos. 2009; 37(8):1611-21. PMC: 2712435. DOI: 10.1124/dmd.109.027565. View

13.

Jaeschke H . Glutathione disulfide formation and oxidant stress during acetaminophen-induced hepatotoxicity in mice in vivo: the protective effect of allopurinol. J Pharmacol Exp Ther. 1990; 255(3):935-41. View

14.

Dart R, Green J, Kuffner E, Heard K, Sproule B, Brands B . The effects of paracetamol (acetaminophen) on hepatic tests in patients who chronically abuse alcohol - a randomized study. Aliment Pharmacol Ther. 2010; 32(3):478-86. DOI: 10.1111/j.1365-2036.2010.04364.x. View

15.

Pumford N, Roberts D, BENSON R, Hinson J . Immunochemical quantitation of 3-(cystein-S-yl)acetaminophen protein adducts in subcellular liver fractions following a hepatotoxic dose of acetaminophen. Biochem Pharmacol. 1990; 40(3):573-9. DOI: 10.1016/0006-2952(90)90558-3. View

16.

Pumford N, Halmes N, Martin B, Cook R, Wagner C, Hinson J . Covalent binding of acetaminophen to N-10-formyltetrahydrofolate dehydrogenase in mice. J Pharmacol Exp Ther. 1997; 280(1):501-5. View

17.

Lu Z, Bourdi M, Li J, Aponte A, Chen Y, Lombard D . SIRT3-dependent deacetylation exacerbates acetaminophen hepatotoxicity. EMBO Rep. 2011; 12(8):840-6. PMC: 3147261. DOI: 10.1038/embor.2011.121. View

18.

de Morais S, Uetrecht J, Wells P . Decreased glucuronidation and increased bioactivation of acetaminophen in Gilbert's syndrome. Gastroenterology. 1992; 102(2):577-86. DOI: 10.1016/0016-5085(92)90106-9. View

19.

Nakagawa H, Maeda S, Hikiba Y, Ohmae T, Shibata W, Yanai A . Deletion of apoptosis signal-regulating kinase 1 attenuates acetaminophen-induced liver injury by inhibiting c-Jun N-terminal kinase activation. Gastroenterology. 2008; 135(4):1311-21. DOI: 10.1053/j.gastro.2008.07.006. View

20.

Nolan C, Sandblom R, Thummel K, Slattery J, Nelson S . Hepatotoxicity associated with acetaminophen usage in patients receiving multiple drug therapy for tuberculosis. Chest. 1994; 105(2):408-11. DOI: 10.1378/chest.105.2.408. View